Monitoring measurable residual disease and chimerism in patients with JAK2 V617F-positive myelofibrosis after allogeneic hematopoietic cell transplantation

• Jong-Mi Lee,
• Ari Ahn,
• Eun Jeong Min,
• Sung-Eun Lee,
• Myungshin Kim,
• Yonggoo Kim

Affiliations

Jong-Mi Lee

Department of Laboratory Medicine, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea

Ari Ahn

Catholic Genetic Laboratory Center, College of Medicine, The Catholic University of Korea

Eun Jeong Min

Department of Medical Life Sciences, College of Medicine, The Catholic University of Korea

Sung-Eun Lee

Department of Hematology, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea

Myungshin Kim

Department of Laboratory Medicine, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea

Yonggoo Kim

Department of Laboratory Medicine, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea